The Size of the Europe Nerve Repair and Regeneration Market is valued at USD 2 billion in 2020 and estimated to be growing at a CAGR of 11.62%, to reach USD 3.47 billion by 2025 during the forecast period 2020-2025.
Nerve Repair and Regeneration refers to the regrowth or repair of nervous tissues, cells or cell products. Such mechanisms may include the generation of new neurons, glia, axons, myelin, or synapses. Neuroregeneration differs between the peripheral nervous system (PNS) and the central nervous system (CNS) by the functional mechanisms and especially the extent and speed.
As a result of this high incidence of neurological injuries, nerve regeneration, and repair, a subfield of neural tissue engineering, is becoming a rapidly growing field dedicated to the discovery of new ways to recover nerve functionality after injury. The nervous system consists of the central nervous system, which consists of the brain and spinal cord, and the peripheral nervous system, which consists of cranial and spinal nerves along with their associated ganglia.
It is only the peripheral nervous system has an intrinsic ability for repair and regeneration, whereas the central nervous system is, for the most part, incapable of self-repair and regeneration. This leaves it vulnerable and if any damage were to occur to it, there is currently no treatment for recovering human nerve function after injury to the central nervous system.
The major factors affecting the Europe Nerve Repair and Regeneration Market include as mentioned before the high incidence of neurological injuries. Other major factors bolstering the nerve repair and regeneration market include favorable reimbursement policies, technological advancements, and willingness to spend on research and development and increasing consumer awareness. As for the restraints of the market, the exorbitant costs of the procedure continue to be the major deterrent along with the technical proficiency required from practitioners.
Europe Nerve Repair and Regeneration Market has been segmented and sub-segmented into the following categories
On the basis of region, the European region has the second-highest market share globally only behind the likes of North America, albeit with a low CAGR rate.
The low growth rate of the region can be attributed to the fact that most countries in the region are in their pinnacle of development and the room to grow is fast decreasing.
Prominent Companies Operating the Europe Nerve Repair and Regeneration Market Profiled in the Report are Baxter International, AxoGen, Boston Scientific Incorporation, Integra Lifesciences Corporation, Cyberonics, Medtronic, Polyganics B.V., Orthomed S.A.S., Stryker Corporation, and St. Jude Medical.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Internal Neurostimulation Devices
5.1.2.1 Spinal Cord Stimulation
5.1.2.2 Deep Brain Stimulation
5.1.2.3 Vagus Nerve Stimulation
5.1.2.4 Sacral Nerve Stimulation
5.1.2.5 Gastric Electrical Stimulation
5.1.3 External Neurostimulation Devices
5.1.3.1 Transcutaneous Electrical Nerve Stimulation
5.1.3.2 Transcranial Magnetic Stimulation
5.1.4 Biomaterials
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Neurostimulation and Neuromodulation Surgeries
5.2.3 Direct Nerve Repair
5.2.4 Nerve Grafting
5.2.5 Stem Cell Therapy
5.2.6 Y-o-Y Growth Analysis, By Application
5.2.7 Market Attractiveness Analysis, By Application
5.2.8 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Application
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Axogen
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Baxter International
8.3 Boston Scientific Corporation
8.4 Cyberonics
8.5 Integra Lifesciences Holdings Corporation
8.6 Medtronic PLC
8.7 ST. Jude Medical
8.8 Stryker Corporation
8.9 Orthomed S.A.S
8.10 Polyganics B.V.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
